Looking back at the past two years, there were many lessons learned and put into legal proposals to amend our mandate, part of this in particular is about the strenghthening of the preparedness and updating surveillance for future crises.
There is really no doubt that the pandemic is not over yet and that there is no time for complacency now.
There are still many individuals at risk of severe #COVID19 infection whom we need to protect as soon as possible.
This signals the start of a new, widespread #COVID19 wave across the European Union. So there is no time for complacency and there are still too many individuals at risk of severe COVID-19 infection whom we need to protect as soon as possible.
@EU_Health @europarl_en @EU_Commission @Eurosurveillanc @EMA_News @EFSA_EU @EU_ECHA @WHO_Europe We are currently seeing a surge in the #COVID19 case notification rates across Europe, as well as an increasing trend in hospital, ICU admissions and occupancy in several EU and EEA countries.
These cases are mainly driven by the BA.5 sublineage of #Omicron.
Starting now #LIVE:
Exchange of views on #COVID19 pandemic with the #ECDC Director - Dr Andrea Ammon & #HERA Director General - Pierre Delsaux.
Watch live here:
https://multimedia.europarl.europa.eu/en/webstreaming/special-committee-on-covid-19-pandemic_20220713-0900-COMMITTEE-COVI
RT @EMSA_EU: For two decades, we have worked together with our partners in other EU Agencies to serve EU citizens 🇪🇺
Thank you, Dr Andrea Ammon @ECDC_EU for all our joint work and cooperation together, and for your message on our 20th anniversary!
⬇️
RT @ECDC_HIVAIDS: #JustPublished:
Congenital #syphilis - Annual Epidemiological Report for 2019.
Read the full report here: https://www.ecdc.europa.eu/en/publications-data/congenital-syphilis-annual-epidemiological-report-2019
RT @EFSA_EU: #Antibiotics misuse in human and veterinary medicine can lead to #AntimicrobialResistance, which happens when bacteria or viruses develop a resistance to the drugs we use to treat them.
Learn more about #AMR and how it's linked to #FoodSafety.
https://ow.ly/5STi50JPtiK
RT @EU_Health: ‼️ We're working towards possible approvals of adapted vaccines
But, in the meantime, consider using currently authorised vaccines as second boosters in people over 60 & the most vulnerable
➡️Every COVID-19 infection that's prevented is a potential life saved
RT @EMA_News: #COVID19 update: recommendations on additional #booster doses
@ECDC and EMA recommend that 2nd boosters of mRNA #COVID19vaccines be considered for people above 60 years and vulnerable persons.
Read the full statement 👇
@SergioEfe Hello Sergio!
In the joint #ECDC/@EMA_News statement you have a bit more of background for the need of use of what is currently approved during the summer wave.
RT @ansaeuropa: L'@ECDC_EU e l'@EMA_News raccomandano la somministrazione del secondo #richiamo del #vaccino anti-#Covid a tutti coloro che hanno più di 60 anni e alle persone vulnerabili. @SKyriakidesEU
https://www.ansa.it/europa/notizie/rubriche/altrenews/2022/07/11/ema-ecdc-raccomandano-il-secondo-richiamo-per-gli-over-60_cd93b820-135c-4b8f-b03c-4d6b82b8987f.html
RT @EU_Health: Important update from @ECDC_EU & @EMA_News as #COVID19 cases & hospitalisations increase 👇🏻
🛡️#COVID19 vaccines protect against severe illness & hospitalisation so every shot matters if we want to protect ourselves, our loved ones & more vulnerable populations
RT @SKyriakidesEU: Member States should roll out second boosters for everyone over the age of 60 as well as all vulnerable persons immediately.
I urge all those eligible to come forth and get vaccinated.
This is how we protect ourselves, our loved ones and our vulnerable populations.
RT @SKyriakidesEU: With #COVID19 numbers rising again in Europe, I urge everybody to get vaccinated and boosted as quickly as possible.
There is no time to lose.
Our vaccines work, and offer good levels of protection against severe illness and hospitalisation.
#ECDC and #EMA will continue to closely evaluate emerging vaccine effectiveness & epidemiological data and will update their recommendations accordingly.
More about the latest advice on 2nd booster doses is available in the joint statement here:
https://bit.ly/3P07uQR
#COVID19
There is no clear evidence to support giving a 2nd booster dose to people <60 years of age not at higher risk of severe disease.
Neither is there clear evidence to support giving them to healthcare workers unless they are at high risk.
https://www.ecdc.europa.eu/en/covid-19
#COVID19
Unofficial automated mirror. No copyright asserted. ∎ The European Centre for Disease Prevention and Control. We aim to strengthen #Europe's defences against infectious diseases.